Current Topics in Medicinal Chemistry

Editor-in-Chief:

Allen B. Reitz
Fox Chase Chemical Diversity Center, Inc.
Doylestown, PA
USA

Back

Become EABM
Become Reviewer

Editorial [ Hot Topic: DPP-IV as a Target in Medicinal Chemistry and Drug Discovery (Guest Editor: Dr. Jens-Uwe Peters) ] promotion: free to download

Volume:7   Issue:6
Pp: 545-545
Jens-Uwe Peters
DOI: 10.2174/156802607780091037

Dipeptidyl Peptidase IV Inhibitors: The Next Generation of New Promising Therapies for the Management of Type 2 Diabetes

Volume:7   Issue:6
Pp: 547-555
Elena Sebokova, Andreas D. Christ, Markus Boehringer and Jacques Mizrahi
DOI: 10.2174/156802607780091019

Aromatic Heterocycle-Based DPP-IV Inhibitors: Xanthines and Related Structural Types.

Volume:7   Issue:6
Pp: 569-578
Bruce G. Szczepankiewicz and Ravi Kurukulasuriya
DOI: 10.2174/156802607780091073

11 Years of Cyanopyrrolidines as DPP-IV Inhibitors

Volume:7   Issue:6
Pp: 579-595
Jens-Uwe Peters
DOI: 10.2174/156802607780091000

Azetidine-Based Inhibitors of Dipeptidyl Peptidase IV (DPP IV)

Volume:7   Issue:6
Pp: 597-608
Dana Ferraris, Sergei Belyakov, Weixing Li, Eddie Oliver, Yao-Sen Ko, David Calvin, Susan Lautar, Bert Thomas and Camilo Rojas
DOI: 10.2174/156802607780090993

Molecular Recognition of Ligands in Dipeptidyl Peptidase IV

Volume:7   Issue:6
Pp: 609-620
Bernd Kuhn, Michael Hennig and Patrizio Mattei
DOI: 10.2174/156802607780091064

Prolyl Peptidases Related to Dipeptidyl Peptidase IV: Potential of Specific Inhibitors in Drug Discovery.

Volume:7   Issue:6
Pp: 621-635
Pieter Van der Veken, Achiel Haemers and Koen Augustyns
DOI: 10.2174/156802607780091046

Molecule of the Month

Volume:7   Issue:6
Pp: 637-637
Craig W. Lindsley
DOI: 10.2174/156802607780091055